Ligand Pursuing Plans for OmniAb to Become a Standalone Public Company

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. AZN
6. ROIV
7. AAPL
8. HOOD
9. QCOM
10. ACN

Go back to Ligand Pursuing Plans for OmniAb to Become a Standalone Public Company
LIGAND PHARMA (NASDAQ: LGND) Delayed: 288.83 +3.23 (1.13%)
Previous Close $285.60    52 Week High $139.79 
Open $285.05    52 Week Low $82.07 
Day High $289.28    P/E 671.70 
Day Low $278.40    EPS $0.43 
Volume 216,206